Pharma company shoots down media report, as an extraordinary row over vaccines supply in Europe gets uglier

European Investment Bank warns innovation spending will be one of most affected areas of the economy as the COVID-19 crisis takes a toll

US biotech Moderna says its vaccine can be repurposed ‘in weeks’ to deal with coronavirus mutations

Open science has been at the heart of the fight-back against the virus. As other crises loom, this underlines the need for governments to avoid protectionist moves and foster collaborative international research

Amid pressure to speed up vaccination programmes some member states are starting to go their own way on securing doses. The EU’s head vaccine official says no country can jump the queue

The pandemic has both spurred on and demonstrated the value of open science, but has also exposed gaps in science policy. Now is a good time for reform, says OECD

A miserable year, we all agree. But there were a few positive developments worth recalling…

As Horizon legislation wraps up, EU commissioner reflects on how R&I in climate, agriculture, food and related sectors can help Europe recover from the pandemic